Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer
T. H. van Dijk, Klaas Havenga(University Medical Center Groningen), Irıs D. Nagtegaal(Radboud University Nijmegen), K.P. de Jong(University Medical Center Groningen), Theo Wiggers(University Medical Center Groningen), H.J.T. Rutten(Radboud University Nijmegen), Geerard L. Beets(The Netherlands Cancer Institute), A. J. Gelderblom(Leiden University Medical Center), K Tamás, Geke A.P. Hospers(University Medical Center Groningen), Cornelis JH van de Velde(Leiden University), Jannet C. Beukema(University Medical Center Groningen)
Cited by 147
Related Papers
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Gastric cancer
|The Lancet|2009|890
Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials.
|Journal of Clinical Oncology|1993|552
Preoperative chemotherapy for women with operable breast cancer
|Cochrane Database of Systematic Reviews|2007|408
The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review.
|Journal of Clinical Oncology|1991|328